Clinical Trial Update: TandemHeart to Reduce Infarct Size (TRIS Trial) [NA]

View source ↗

Summary

The TRIS Trial evaluating TandemHeart to reduce infarct size in acute myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TandemHeart

Snippet

Sponsor: CardiacAssist, Inc. | Conditions: Acute Myocardial Infarction | NA | Status: WITHDRAWN